Kinase activities in pancreatic ductal adenocarcinoma with prognostic and therapeutic avenues

Kinase activities in pancreatic ductal adenocarcinoma with prognostic and therapeutic avenues

Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease with a limited number of known driver mutations but considerable cancer cell heterogeneity. Phosphoproteomics provides a direct read‐out of aberrant signaling and the resultant clinically relevant phenotype. Mass spectrometry (MS)‐base...

Full description

Bibliographic Details
Main Authors: Andrea Vallés‐Martí, Richard R. deGoeij‐de Haas, Alex A. Henneman, Sander R. Piersma, Thang V. Pham, Jaco C. Knol, Joanne Verheij, Frederike Dijk, Hans Halfwerk, Elisa Giovannetti, Connie R. Jiménez, Maarten F. Bijlsma
Format: Article
Language:English
Published: Wiley 2024-08-01
Series:Molecular Oncology
Subjects:
kinase activity
pancreatic ductal adenocarcinoma
personalized medicine
phosphoproteome
Online Access:https://doi.org/10.1002/1878-0261.13625

Internet

https://doi.org/10.1002/1878-0261.13625

Similar Items